Olanzapine pamoate monohydrate

CAS: 221373-18-8

Ref. 3D-FO26540

Informação sobre produto

• Nome: Olanzapine pamoate monohydrate
• Sinónimos: 4,4'-Methylenebis[3-hydroxy-2-naphthalenecarboxylic acid compound with 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]ben zodiazepine hydrate2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine 4,4'-methylenebis[3-hydro, Olanzapine pamoate [USAN], 10H-Thieno(2,3-b)(1,5)benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)-, 4,4'-methlenebis(3-hydroxy-2-naphthalenecarboxylate) (1:1), monohydrate, 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine pamoate monohydrate, Unii-X7S6Q4Mhcb, Zyprexa Relprevv

Descrição

Olanzapine pamoate monohydrate is a prodrug of the antipsychotic drug Olanzapine. It is used for the treatment of schizophrenia and bipolar disorder. The prodrug is converted to Olanzapine in vivo, which binds to histamine H1 receptors and blocks dopamine D2 receptors. This results in an antipsychotic effect, as well as a reduction in manic episodes associated with bipolar disorder. Olanzapine pamoate has been shown to be effective in treating schizophrenia, bipolar disorder, and major depressive disorder with psychotic features. The prodrug has also been shown to have a high oral bioavailability, good tissue distribution, and low toxicity.

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 718.82 g/mol
• Fórmula: C₄₀H₃₈N₄O₇S
• Pureza: Min. 95%